Welcome to our dedicated page for Tilt Hldgs news (Ticker: TLLTF), a resource for investors and traders seeking the latest updates and insights on Tilt Hldgs stock.
TILT Holdings Inc. (TLLTF) generates a wide range of company news tied to its role as a global provider of cannabis business solutions. Its disclosures describe a portfolio that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, with a core focus on Jupiter Research LLC, a wholly owned subsidiary active in vaporization hardware design, research, development, manufacturing and distribution. News about TILT often highlights how these activities support cannabis brands and retailers across North America, South America, Israel and the European Union.
Recent announcements show that TILT’s news flow covers both operational performance and strategic restructuring. Earnings releases discuss quarterly financial and operating results, including revenue trends, gross margin dynamics and the impact of strategic shifts such as divesting plant-touching assets in Massachusetts and Ohio or transitioning parts of Jupiter’s business to a commission-based model. Operational updates also describe regulatory approvals, such as European Union medical device certification for a handheld liquid inhalation device developed by Jupiter, and agreements with partners like Curaleaf International for commercialization in medical markets.
Another important stream of news relates to capital structure and creditor arrangements. TILT has reported entering into secured note purchase agreements for bridge financing, receiving default notices from landlords on certain cultivation properties, and negotiating forbearance arrangements. The company has also issued multiple releases about its CCAA restructuring process in the Supreme Court of British Columbia, including the initial order granting creditor protection, the proposed plan of arrangement to take the company private, and notices of meetings for noteholders.
For users following TLLTF on this news page, the coverage provides a consolidated view of TILT’s financial results, restructuring milestones, asset sales, regulatory certifications and governance events such as shareholder meeting outcomes. Investors and observers can use this archive to trace how TILT’s strategy has evolved toward Jupiter-centered, asset-light operations and to understand the context behind its delisting and restructuring decisions.
TILT Holdings Inc. (TLLTF) will take part in two upcoming conferences: MJ Unpacked in Las Vegas from September 28-30, 2022, where CEO Gary Santo will engage in a panel discussion, and the Alliance Global Partners Virtual Fall Consumer Cannabis Conference on October 4, 2022, featuring management in one-on-one meetings. TILT provides extensive cannabis business solutions, including inhalation technologies and retail services, across 37 U.S. states and several international markets. The company focuses on brand development, cultivation, and processing.
TILT Holdings Inc., a provider of cannabis business solutions, held a grand opening for its new medical marijuana dispensary in Cambridge, Massachusetts, on September 16, 2022. The event featured a ribbon-cutting ceremony and remarks from CEO Gary Santo, alongside former NFL player Ricky Williams, whose brand products launched in Massachusetts. The dispensary aims to offer high-quality marijuana products to medical patients and build community relations through local partnerships. This marks TILT's third dispensary in Massachusetts, following openings in Brockton and Taunton.
TILT Holdings announced the launch of Highsman, a cannabis lifestyle brand by former NFL star Ricky Williams, in Massachusetts. The brand, focused on breaking cannabis stigma, offers new strains like Pregame, Halftime, and Postgame. Williams will participate in the Cambridge ribbon-cutting ceremony on September 16, 2022. This launch is part of Highsman's expansion, with Pennsylvania expected to follow soon. Products are available at Commonwealth Alternative Care locations and through TILT's wholesale channels, aiming to cater to both patients and adult-use consumers.
Summary not available.
TILT Holdings Inc. announced that its subsidiary, Commonwealth Alternative Care Inc., secured third place in the 'Solvent Concentrates' category at the Massachusetts Cultivators Cup. The event, held over Labor Day weekend, featured submissions from ten licensed cultivators. TILT's NF1 Badder, a cannabis strain crossbred from Northern Lights and Chemdawg, was recognized for its quality. This award follows previous accolades at the 2022 NECANN Competition, highlighting TILT's commitment to producing award-winning cannabis products.
TILT Holdings Inc. (OTCQX: TLLTF) announced that CEO Gary Santo will speak at the Benzinga Cannabis Capital Conference in Chicago on September 14, 2022. Santo will participate in a panel titled “Giving Back: The Opportunity in Responsibility,” alongside industry leaders. TILT is also a finalist for two Benzinga Cannabis Awards: Best Cannabis Partnership and Best Use of Capital, with winners to be announced at the event. TILT provides comprehensive cannabis business solutions, including technology and retail services across the U.S. and internationally.
TILT Holdings announces the opening of its Cambridge dispensary on September 2, 2022, following approval from the Massachusetts Cannabis Control Commission. The new facility spans 5,100 square feet and will offer products from TILT’s brands, including flower, concentrates, edibles, and topicals. Located at 1385 Cambridge Street, its operational hours are 9:30 a.m. to 8:00 p.m. on weekdays and until 8:30 p.m. on weekends. This marks TILT's third medical dispensary in Massachusetts, enhancing patient access and expanding their delivery services.
TILT Holdings Inc. reported Q2 2022 financial results, with $47.1 million in revenue, down from $48.5 million year-over-year. Despite a 22% YoY growth in cannabis operations, the company faced challenges in its inhalation business, leading to a net loss of $7.1 million compared to net income of $1.0 million last year. Adjusted EBITDA decreased to $1.1 million. The total cash balance rose to $34.7 million, and TILT revised its 2022 revenue guidance to $205-$210 million due to macroeconomic pressures. New brand partnerships and product launches are expected to drive future growth.
TILT Holdings Inc. (OTCQX: TLLTF) has launched its 1906 cannabis products in Pennsylvania through its subsidiary, Standard Farms. This marks the first roll-out from a previously announced multi-state collaboration with 1906, highlighting TILT's commitment to expanding its brand portfolio. The initial offerings include the new Boost Discovery Pouch featuring THC Drops. Ohio is set for a late August release of additional products, reinforcing TILT's strategy to enhance accessibility for patients in significant medical markets.
TILT Holdings (TLLTF) has launched its Toast products in Massachusetts, available at Commonwealth Alternative Care locations and wholesale partners. This rollout marks the first phase of a previously announced multi-state agreement between TILT and Toast. The Toast Slices, featuring a blend of CBD and THC, cater to both new and experienced cannabis consumers. The company aims for further expansion into Ohio by fall 2022. TILT's CEO emphasized teamwork and product integrity as key to this successful launch.